D. B. Sanders, R. C. Bittner, M. Rosenfeld, L. R. Hoffman, G. J. Redding et al., Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation, Am J Respir Crit Care Med, vol.182, pp.627-632, 2010.

M. D. Parkins, J. C. Rendall, and J. S. Elborn, Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa, Chest, vol.141, pp.485-493, 2012.

D. B. Sanders, L. R. Hoffman, and J. Emerson, Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis, Pediatr Pulmonol, vol.45, pp.127-134, 2010.

S. Esposito, V. Dacc-o, and C. Daleno, Human rhinovirus infection in children with cystic fibrosis, Jpn J Infect Dis, vol.67, pp.399-401, 2014.

S. Zheng, B. P. De, and S. Choudhary, Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis, Immunity, vol.18, pp.619-630, 2003.

S. Asner, V. Waters, and M. Solomon, Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis, J Cyst Fibros, vol.11, pp.433-439, 2012.

A. R. Smyth, R. L. Smyth, C. Y. Tong, C. A. Hart, and D. P. Heaf, Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis, Arch Dis Child, vol.73, pp.117-120, 1995.

D. Bilton, G. Canny, and S. Conway, Report from the EuroCareCF Working Group on outcome parameters in clinical trials, J Cyst Fibros, vol.10, issue.2, pp.79-81, 2011.

D. R. Vandevanter, M. A. O'riordan, J. L. Blumer, and M. W. Konstan, Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations, Respir Res, vol.11, p.137, 2010.

A. L. Smith, S. B. Fiel, N. Mayer-hamblett, B. Ramsey, and J. L. Burns, Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis, Chest, vol.123, pp.1495-1502, 2003.

L. Saiman, N. Mayer-hamblett, P. Campbell, and B. C. Marshall,

M. Study-group, Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis, Am J Respir Crit Care Med, vol.172, pp.1008-1012, 2005.

G. D?-oring, P. Flume, H. Heijerman, and J. S. Elborn, Consensus Study Group. Treatment of lung infection in patients with cystic fibrosis: current and future strategies, J Cyst Fibros, vol.11, pp.461-479, 2012.

C. R. Esther, F. C. Lin, A. Kerr, M. B. Miller, and P. H. Gilligan, Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis, Pediatr Pulmonol, vol.49, pp.926-931, 2014.

S. E. Jacobs, D. M. Lamson, K. St-george, and T. J. Walsh, Human rhinoviruses, Clin Microbiol Rev, vol.26, pp.135-162, 2013.

E. N. Sutanto, A. Kicic, and C. J. Foo, Innate inflammatory responses of pediatric cystic fibrosis airway epithelial cells: effects of nonviral and viral stimulation, Am J Respir Cell Mol Biol, vol.44, pp.761-767, 2011.